Shebli Atrash, MD

Articles by Shebli Atrash, MD

Survival Outcomes of Selinexor-Containing Triplets in Myeloma

Shebli Atrash, MDMyeloma | October 25, 2024

Dr. Atrash reviews real-world data on four selinexor-based triplets used in the treatment of relapsed or refractory myeloma.